GlassScriptPhysician profile
Bharat Jain
NPI 1366448508
$8,541.10
in general payments reported to CMS, 2019-2025
34 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $822 · 2021: $710 · 2022: $1,067 · 2023: $1,220 · 2024: $2,085 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,529 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,529.32 |
| Education | $246.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,830.65 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $1,229.33 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $506.79 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $463.60 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $334.13 | 2021-2025 | Wakix |
| Grifols USA, LLC | $309.64 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $283.26 | 2019-2024 | Dupixent |
| Axsome Therapeutics, INC. | $274.89 | 2023-2025 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.17 | 2019-2025 | Ofev, Jascayd |
| Insmed, INC. | $266.51 | 2022-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $232.58 | 2019-2024 | Yupelri |
| Resmed Corp | $194.47 | 2024 | |
| Philips North America LLC | $160.25 | 2019-2024 | (Ak6) Vest Therapy, (8874) Incourage |
| Genzyme Corporation | $146.53 | 2019-2025 | |
| Verona Pharma, INC. | $135.43 | 2025 | Ohtuvayre |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $132.51 | 2019-2020 | |
| Inspire Medical Systems, INC. | $118.88 | 2023-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $77.21 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.81 | 2022 | |
| Electromed, INC. | $68.30 | 2019-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $57.27 | 2019-2023 | |
| Zoll Respicardia, INC. | $55.25 | 2024-2025 | Remede System |
| Circassia INC. | $52.19 | 2019 | |
| Genentech USA, INC. | $42.53 | 2019 | |
| Azurity Pharmaceuticals, INC. | $37.23 | 2024-2025 | Alvesco, Horizant |
| Pulmonx Corporation | $35.42 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Amgen INC. | $30.64 | 2022-2024 | Tezspire |
| Fisher & Paykel Healthcare INC | $26.06 | 2025 | Fisher & Paykel Healthcare |
| Baxter Healthcare | $20.92 | 2024 | Hillrom - Monarch Airway Clearance System |
| Tactile Systems Technology INC | $18.66 | 2024 | Flexitouch Plus, Entre Plus |
| Hikma Pharmaceuticals USA | $16.14 | 2023 | Ryaltris |
| Gilead Sciences, INC. | $14.73 | 2021 | |
| Pfizer INC. | $12.73 | 2023 | |
| Advanced Respiratory, INC | $11.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.